Ειδήσεις: OBESITY DRUG | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

02/04 00:06 bloomberg.com

Novo VP Weighs In on Approval of Lilly’s Obesity Pill

Novo Nordisk Lilly tirzepatide obesity drug FDA approval GLP‑1

01/04 23:07 npr.org

The FDA approves a new obesity pill, giving patients another option

FDA approval obesity drug Foundayo Wegovy weight‑loss daily pill

01/04 21:01 bloomberg.com

Novo Digs in to Protect Its No. 1 Spot in Obesity Pill Market

Novo Nordisk Wegovy obesity drug market dominance prescription weight loss pharmaceutical strategy

01/04 18:46 statnews.com

Eli Lilly’s obesity pill approved by FDA, setting up fierce competition with Novo Nordisk

Eli Lilly obesity drug FDA approval Foundayo orforglipron Novo Nordisk

01/04 16:40 statnews.com

STAT+: Novo’s subscription model raises questions about pharma-telehealth tie-ups

Novo Nordisk subscription model obesity drugs telehealth pharma partnerships pricing strategy

30/03 06:10 bloomberg.com

Innovent Biologics Bullish on China Obesity Drug Outlook

Innovent Biologics obesity drug China market pharmaceutical optimism regulatory support sales growth

26/03 05:46 x.com

Nancy Thomas: I’m not trading for a living—just supplementing income. @alvizuri1992 ’s real-time help keeps my wins steady and my trades easy...

Nancy Thomas trading real-time help stocks crypto obesity drug

26/03 03:14 x.com

Charles Brown: Closing thought from a regular investor: Experience taught me a lot; @alvizuri1992 ’s real-time guidance makes it profitable and...

Investor Real-time Guidance Profitable Trading Stocks Crypto Obesity Drug

26/03 01:10 x.com

Jennifer Torres: Just a normal person trading stocks, learning every day. @alvizuri1992 ’s live updates give me steady profits and strategies I...

stock trading daily learning live updates profit strategies crypto obesity drug

26/03 01:10 x.com

Jennifer Torres: Just a normal person trading stocks, learning every day. @alvizuri1992 ’s live updates give me steady profits and strategies I...

stock trading daily learning live updates profit strategies crypto obesity drug

Loading...